Currently Viewing:
Currently Reading
What We're Reading: The New Way to Price Drugs
August 09, 2016 – AJMC Staff
Infographic: 5 Key Healthcare Differences Between Clinton and Trump
August 08, 2016
ED Death Rates Fall by Nearly 50% From 1997 to 2011
August 07, 2016 – Jackie Syrop
CheckMate-026 Fails in Phase 3 - Nivolumab Monotherapy Does Not Improve PFS in NSCLC
August 05, 2016 – Surabhi Dangi-Garimella, PhD
What We're Reading: Anthem, Aetna Merger Lawsuits Unlikely to Be Decided by End of 2016
August 05, 2016 – AJMC Staff
Knowing Which RCC Patients Do Not Qualify for Nivolumab Treatment
August 04, 2016 – Surabhi Dangi-Garimella, PhD
Aetna, Humana Try to Save Their Merger by Selling Assets to Molina Healthcare
August 04, 2016 – Laura Joszt
Avalere Health Projects Outpatient Spending Biggest Driver of 2017 Premium Increases
August 04, 2016 – Surabhi Dangi-Garimella, PhD
Nivolumab Passes QOL Test in Melanoma
August 03, 2016 – Surabhi Dangi-Garimella, PhD

What We're Reading: The New Way to Price Drugs

AJMC Staff
What we're reading, August 9, 2016: tying drug costs to outcomes is the future of drug pricing; Walgreens expands drug take-back kiosk program; patients with atrial fibrillation need to consult a second doctor before receiving a new medical device.
An article from Reuters Health highlights pricing drugs based on clinical outcomes rather than the number of pills or vials sold as the future of drug pricing. The challenge is that such a pricing model would require improvements in data collection and agreement on the right outcomes to measure. Experiments with new pricing plans have been taking place around the world as governments in European countries, China and Japan, and the United States look to cap runaway costs.

In Illinois, 45 Walgreens drugstores will introduce metal kiosk for people to safely dispose of unwanted medications. According to the Chicago Tribune, the kiosks are meant to provide people with a way of getting rid of prescription or over-the-counter medications without them ending up in the wrong hands. Walgreens already has kiosks installed in 300 stores in 24 states and it plans to make them available in 500 stores around the country.

Before patients with atrial fibrillation can get a recently approved medical device, Medicare is requiring that they consult a second doctor. The purpose of the new rule is to ensure patients’ opinions and values are taken into account before reaching a treatment decision, reported The Wall Street Journal. The new device, Watchman, enables stroke prevention without the use of blood thinners—the standard treatment to prevent clots for people with atrial fibrillation.

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up